Anemos Therapeutics an Italian biopharmaceutical firm, transforms drugs into potent inhalatory formulations for greater efficacy and safety leveraging its ANEMOS™ proprietary particle engineering technology.
With optimized lung deposition and therapeutic efficacy, the Anemos technological approach can transform medicines into efficient dry powders that are very favorable for inhalation.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Manufacturing
- NAICS
-
ManufacturingBeverage and Tobacco Product ManufacturingMiscellaneous ManufacturingTextile Furnishings MillsOther Textile Product MillsOther Miscellaneous ManufacturingCarpet and Rug MillsCurtain and Linen MillsTextile Bag and Canvas MillsAll Other Textile Product MillsJewelry and Silverware ManufacturingDoll, Toy, and Game ManufacturingOffice Supplies (except Paper) ManufacturingSign ManufacturingAll Other Miscellaneous ManufacturingRope, Cordage, Twine, Tire Cord, and Tire Fabric MillsAll Other Miscellaneous Textile Product MillsGasket, Packing, and Sealing Device ManufacturingMusical Instrument ManufacturingFastener, Button, Needle, and Pin ManufacturingBroom, Brush, and Mop ManufacturingBurial Casket Manufacturing
- Website
- http://www.anemostx.com
- Keywords
- Farmaceutico.
Anemos Therapeutics Questions
Anemos Therapeutics's website is http://www.anemostx.com
Anemos Therapeutics's LinkedIn profile is https://www.linkedin.com/company/anemos-therapeutics
Anemos Therapeutics has
2 employees.
View email and phone details for 2
employees at Anemos Therapeutics.
Anemos Therapeutics's industry is
Manufacturing
Anemos Therapeutics's top competitors are
Kupando Gmbh,
Molsid,
Nuvamid,
Limula,
Bioexpert Network,
Lys Therapeutics,
Genespire,
Cansino Biologics Inc.康希诺生物,
Ibex Therapeutics,
The Global Centre For Risk And Innovation (Gcri).
Anemos Therapeutics's categories are Manufacturing
Anemos Therapeutics's founding year is 2024
